Cargando…
Oncologist-led BRCA ‘mainstreaming’ in the ovarian cancer clinic: A study of 255 patients and its impact on their management
Although guidelines recommend BRCA testing for all women with non-mucinous epithelial ovarian cancer, there is significant variability in access to testing across the UK. A germline BRCA mutation (BRCAm) in ovarian cancer patients provides prognostic and predictive information and influences clinica...
Autores principales: | Rumford, Megan, Lythgoe, Mark, McNeish, Iain, Gabra, Hani, Tookman, Laura, Rahman, Nazneen, George, Angela, Krell, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042365/ https://www.ncbi.nlm.nih.gov/pubmed/32098980 http://dx.doi.org/10.1038/s41598-020-60149-5 |
Ejemplares similares
-
Safe administration of chemotherapy in mast cell activation syndrome
por: Lythgoe, MP, et al.
Publicado: (2020) -
Practical guidance for the management of side effects during
rucaparib therapy in a multidisciplinary UK setting
por: Tookman, Laura, et al.
Publicado: (2020) -
Response to the letter entitled “Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers”
por: Samani, A., et al.
Publicado: (2022) -
Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer
por: Kemp, Zoe, et al.
Publicado: (2019) -
Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers
por: Samani, A., et al.
Publicado: (2022)